Skip to content

Exploratory Clinical Study on the Treatment of Varicocele with Seminal Abnormality with Zishen Yutai Pill

Exploratory Clinical Study on the Treatment of Varicocele with Seminal Abnormality with Zishen Yutai Pill

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000516
Enrollment
Unknown
Registered
2024-10-09
Start date
2024-11-30
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

varicocele

Interventions

control group:Do not take the Zishen Yutai Pill

Sponsors

Reproductive Health Research Institute Tongji Medical College Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 48 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for varicocele and undergoes microsurgical varicocele surgery; (2) Abnormal preoperative semen parameters with sperm concentration between 1×10^6/ml and less than 15×10^6/ml or progressive motility (PR) between 1% and less than 32%; (3) The patient's age is between 18 and 48 years old; (4) Volunteers to participate in this clinical trial and signs an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Congenital obstruction of the vas deferens genital organ deformity; (2) Severe oligospermia severe asthenospermia; Criteria: Sperm concentration <1×10^6/mL sperm progressive motility (PR) <1%; (3) Within the recent month taken drugs for treating this disease related to kidney tonification and sperm production; (4) With severe primary diseases of heart liver kidney and other systemic diseases or mental diseases.

Design outcomes

Primary

MeasureTime frame
sperm concentration;sperm forward progression;

Secondary

MeasureTime frame
DFI;Infection diagnosis;Sperm Morphology Analysis;Seminal plasma biochemistry;testicular volume;Oxidative Stress Indicators;Serum Testosterone;Antisperm antibodies;Immune factor indicators;Semen volume;Visual Analogue Scale (VAS) for pain;

Countries

China

Contacts

Public ContactZhang Huiping

Reproductive Health Research Institute Tongji Medical College Huazhong University of Science and Technology

zhpmed@126.com18986163567

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026